https://www.zacks.com/stock/news/2272441/brookdale-bkd-down-3-post-q1-earnings-what-lies-ahead?cid=CS-ZC-FT-analyst_blog|earnings_article-2272441
May 10, 2024 - Elevated facility operating costs and lower interest income strain Brookdale's (BKD) Q1 results, which were partly offset by favorable occupancy rates fetching improved resident fees.
zc:-6237473371599897517
0
https://www.zacks.com/stock/news/2270704/pediatrix-md-q1-earnings-beat-on-hospital-contract-fees?cid=CS-ZC-FT-analyst_blog|earnings_article-2270704
May 08, 2024 - Pediatrix's (MD) Q1 results benefit from higher same-unit revenues, resulting from growing patient volumes, partly offset by high costs. It continues to expect 2024 adjusted EBITDA within $200-$220 million.
zc:-8925724031656706826
0
https://www.zacks.com/stock/news/2269942/select-medical-s-sem-shares-up-12-9-since-q1-earnings-beat?cid=CS-ZC-FT-analyst_blog|earnings_article-2269942
May 07, 2024 - Select Medical (SEM) revises its adjusted EBITDA guidance upward between $845 million and $885 million for 2024, the mid-point is higher than $807.4 million in 2023.
zc:6972985295800910859
0
https://www.zacks.com/stock/news/2269026/acadia-healthcare-achc-shares-down-9-despite-q1-earnings-beat?cid=CS-ZC-FT-analyst_blog|earnings_article-2269026
May 06, 2024 - Acadia Healthcare's (ACHC) Q1 results aided by improved revenue per patient day, partly offset by escalating costs. It continues to expect 2024 adjusted EPS within $3.40-$3.70.
zc:-2497324070634926759
0
https://www.zacks.com/stock/news/2268188/ensign-group-ensg-stock-down-2-4-despite-q1-earnings-beat?cid=CS-ZC-FT-analyst_blog|earnings_article-2268188
May 03, 2024 - Ensign Group (ENSG) expects revenues between $4.13 and $4.17 billion, the mid-point of which indicates an improvement of 11.3% from the 2023 figure.
zc:2564930917653610544
0
https://www.zacks.com/stock/news/2267361/cigna-ci-q1-earnings-beat-on-client-wins-in-evernorth-unit?cid=CS-ZC-FT-analyst_blog|earnings_article-2267361
May 02, 2024 - Cigna's (CI) Q1 results reflect strong organic growth in the Evernorth Health Services unit. It expects adjusted EPS of at least $28.40 for 2024, up from the earlier guidance of at least $28.25.
zc:3047771712818341818
0
https://www.zacks.com/stock/news/2266339/tenet-healthcare-thc-beats-on-q1-earnings-ups-24-eps-view?cid=CS-ZC-FT-analyst_blog|earnings_article-2266339
May 01, 2024 - Tenet Healthcare's (THC) Q1 results reflect strength in admissions and improved pricing yield. It expects an adjusted EPS of $8.37-$9.41 for 2024, higher than the earlier mentioned $5.76-$6.90.
zc:8905285411616159177
0
https://www.zacks.com/stock/news/2264352/encompass-health-ehc-stock-down-despite-q1-earnings-beat?cid=CS-ZC-FT-analyst_blog|earnings_article-2264352
Apr 29, 2024 - Encompass Health (EHC) increases its guidance for net operating revenues, which is in the range of $5.25-$5.325 million for 2024.
zc:3070483661695462447
0
https://www.zacks.com/stock/news/2263597/hca-healthcare-s-hca-q1-earnings-beat-on-rising-admissions?cid=CS-ZC-FT-analyst_blog|earnings_article-2263597
Apr 26, 2024 - HCA Healthcare's (HCA) quarterly results gain from broad volume-based growth along with a rising number of surgeries. Rising expenses act as a partial offset.
zc:-4769622020415471464
0
https://www.zacks.com/stock/news/2263590/centene-cnc-q1-earnings-beat-on-premiums-24-eps-view-hiked?cid=CS-ZC-FT-analyst_blog|earnings_article-2263590
Apr 26, 2024 - Centene's (CNC) Q1 results reflect strength in the Commercial business line. Management currently expects adjusted EPS to be greater than $6.80 for 2024.
zc:-4981006403784773772
0